Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3Plasma cell 1Myeloid 1Classical hematology 1CNS 1

Conditions

Anemia, Refractory, with Excess of Blasts 36Leukemia 32Myelodysplastic Syndromes 29Leukemia, Myeloid, Acute 27Leukemia, Myelomonocytic, Chronic 23Congenital Abnormalities 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myeloproliferative Disorders 10Leukemia, Myelomonocytic, Acute 10Blast Crisis 10Leukemia, Monocytic, Acute 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Leukemia, Myeloid, Accelerated Phase 8Anemia, Refractory 8Myelodysplastic-Myeloproliferative Diseases 7Lymphoma 7Thrombocytopenia 6Leukemia, Myeloid, Chronic-Phase 6Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Leukemia, Lymphocytic, Chronic, B-Cell 5Primary Myelofibrosis 4Neoplasms, Plasma Cell 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Hodgkin Disease 4

Interventions

pegfilgrastim 2Epoetin Alfa 2Cisplatin 2sodium thiosulfate 1etoposide phosphate 1Rituximab 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Erythropoietin 1Docetaxel 1Darbepoetin alfa 1Cytarabine 1Cyclophosphamide 1Carboplatin 1Brachytherapy 12,2'-dithiodiethanesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Cytarabine × Classical hematology × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡